Search
for
Sort by
Research 61–90 of 1000+
- Androgen Receptor Actions Modify Skin Structure and Chemical Carcinogen-induced Skin Cancer Susceptibility in Mice
- Androgen antagonists in androgen target tissues
- Early-onset baldness and the risk of aggressive prostate cancer: findings from a case–control study
- Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer
- Androgen deprivation therapy may constitute a more effective COVID-19 prophylactic than therapeutic strategy
- Hepatotoxicity Associated with Anabolic Androgenic Steroids and Selective Androgen Receptor Modulators: A Literature Review
- The evolutionary impact of androgen levels on prostate cancer in a multi-scale mathematical model
- ANTIANDROGEN THERAPY IN DERMATOLOGY
- The Evaluation and Management of Hirsutism
- Effect of Saw Palmetto Supplements on Androgen-Sensitive LNCaP Human Prostate Cancer Cell Number and Syrian Hamster Flank Organ Growth
- Comparison of flutamide and spironolactone in the treatment of hirsutism: a randomized controlled trial
- The secret identities of TMPRSS2: Fertility factor, virus trafficker, inflammation moderator, prostate protector and tumor suppressor
- Alopecia: managing the basics
- Endocrine treatment of benign prostatichypertrophy: Current concepts
- Histopathological Findings and Proliferative Activity of Canine Sebaceous Gland Tumours with a Predominant Reserve Cell Population
- Is dehydroepiandrosterone a hormone?
- 25 years of ERβ: a personal journey
- Molecular targeted therapies for cancer: Sorafenib mono�therapy and its combination with other therapies (Review)
- Cyproterone Acetate: A Genotoxic Carcinogen?
- Increased Incidence of Telogen Effluvium Following Platelet-Rich Plasma Therapy in Patients with Elevated TNF-α Expression: A Prospective Cohort Study
- SARS-CoV-2 vaccination in androgen sensitive phenotypes – A study on associated factors for SARS-CoV-2 vaccination and its adverse effects among androgenetic alopecia and benign prostate hyperplasia patients
- Activated Polyamine Catabolism Depletes Acetyl-CoA Pools and Suppresses Prostate Tumor Growth in TRAMP Mice
- Chapter 23. Therapeutic Control of Androgen Action
- Cutaneous Lymphadenoma Is a Distinct Trichoblastoma-like Lymphoepithelial Tumor With Diffuse Androgen Receptor Immunoreactivity, Notch1 Ligand in Reed-Sternberg–like Cells, and Common EGFR Somatic Mutations
- Insight into Recent Advances in Degrading Androgen Receptor for Castration-Resistant Prostate Cancer
- Androgen Receptor Antagonists (Antiandrogens) Structure-Activity Relationships
- Regulation of masculinization: androgen signalling for external genitalia development
- Prostate Specific Antigen as Predictive Factor for Androgenemia in Women
- Cutaneous Androgen Metabolism: Basic Research and Clinical Perspectives
- Analysis of androgen receptor expression and activity in the mouse brain